Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

European Innovation Council · Running

Laser bioprinting device and in vivo applications Laser bioprinting device and in vivo applications

Coordinator
Phosprint Anonymi Etaireia, Greece
Runs
1 May 2023 to 30 April 2026
Status
Running
EU funding
€2.0m
Total cost
€2.9m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190195672

What the project is doing

In the project's own words, from its summary on CORDIS.

PhosPrint's D-LIB platform technology is based on a compact and automated laser bioprinter and protocols for high-speed and high-precision in-vivo printing of tissues with autologous human body characteristics. The bioprinter relies on the Laser Induced Forward Transfer (LIFT) technique to accomplish highly accurate and cost-effective printing of tissues. The bioprinter system is associated with protocols for cell isolation from autologous biopsies, cell expansion in-vitro, and cell printing in-vivo.

This is a truly new approach that allows for real-time tissue engineering/repair in complex medical conditions. D-LIB capabilities will enable the introduction of a laser bioprinting technology in surgery operations, starting with enterocystoplasty/augmentation in cystectomy bladder cancer patients as the selected go-to-market application.

Topics

Who is involved

OrganisationCityCountryRole
Phosprint Anonymi EtaireiaAgia Paraskevi AthinaGreeceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI